K-numberK260166
Device nameBunkerhill Contrast CAC
ApplicantBunkerHill Health
Product codeJAK
Device classClass II
Decision dateMar 6, 2026
DecisionSubstantially Equivalent
Regulation892.1750
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Bunkerhill Contrast CAC is a software device that automatically analyzes non-gated, contrast-enhanced chest CT images to detect the presence and estimate the quantity of coronary artery calcification in patients aged 30 and above. It outputs a quantification score in cubic millimeters (mm³) and a visual region of interest, intended as an adjunctive tool to assist physicians in reviewing patient cases rather than as a standalone diagnostic.

Technological characteristics

Both the subject device and predicate use deep-learning algorithms to identify and quantify calcification in non-gated CT images in DICOM format. The key difference is that the subject device analyzes contrast-enhanced images and outputs volume in mm³ using a deterministic formula, whereas the predicate analyzes non-contrast images and outputs Agatston Units. Both provide visual regions of interest and serve as optional support tools that do not replace clinical evaluation.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

Bunkerhill Contrast CAC is substantially equivalent to the predicate iCAC Device (K230223) because both devices use identical principles of operation and technological characteristics for detecting and quantifying calcification. The pivotal retrospective validation study demonstrated sensitivity of 0.957, specificity of 0.929, and acceptable Bland-Altman agreement (mean bias 25.41 mm³, LOA –249.13 to 198.32 mm³). A bridging study comparing contrast-enhanced and non-contrast images on the same patients confirmed validity (mean bias –4.36 mm³), with minor differences in image type and output units not raising new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →